title: Dasatinib plus chemotherapy to achieve full donor chimerism and complete molecular remission in a child with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
authors.forename: Gevorg
authors.initials: G
authors.lastname: Tamamyan
authors.forename: Yu-Hua
authors.initials: YH
authors.lastname: Chao
authors.forename: Chung-Hsing
authors.initials: CH
authors.lastname: Wang
authors.forename: Han-Ping
authors.initials: HP
authors.lastname: Wu
authors.forename: Tefu
authors.initials: T
authors.lastname: Weng
authors.forename: Ching-Tien
authors.initials: CT
authors.lastname: Peng
authors.forename: Kang-Hsi
authors.initials: KH
authors.lastname: Wu
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D000069439:Dasatinib; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D019520:Living Donors; D008297:Male; D010677:Philadelphia Chromosome; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000473:pathology / Q000517:prevention & control*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D012008:Recurrence; D012074:Remission Induction; D013844:Thiazoles / Q000008:administration & dosage*; D013997:Time Factors; D018183:Transplantation Chimera; D014184:Transplantation, Homologous
chemical_list: D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib